Craig, Timothy J.
Zaragoza-Urdaz, Rafael H.
Li, H. Henry
Yu, Ming
Ren, Hong
Juethner, Salomé
Anderson, John
,
Clinical trials referenced in this document:
Documents that mention this clinical trial
Effectiveness and safety of lanadelumab in ethnic and racial minority subgroups of patients with hereditary angioedema: results from phase 3 studies
https://doi.org/10.1186/s13223-022-00721-y
Current and emerging biologics for the treatment of hereditary angioedema
https://doi.org/10.1080/14712598.2019.1595581
Documents that mention this clinical trial
Effectiveness and safety of lanadelumab in ethnic and racial minority subgroups of patients with hereditary angioedema: results from phase 3 studies
https://doi.org/10.1186/s13223-022-00721-y
Current and emerging biologics for the treatment of hereditary angioedema
https://doi.org/10.1080/14712598.2019.1595581
Funding for this research was provided by:
Shire Human Genetic Therapies, Inc., a Takeda company
Article History
Received: 31 March 2022
Accepted: 21 August 2022
First Online: 24 September 2022
Declarations
:
: The HELP and HELP OLE studies were conducted in accordance with Good Clinical Practice guidelines and the principles of the Declaration of Helsinki as well as other applicable local ethical and legal requirements. All patients or caregivers provided written informed consent (or assent from patients < 18 years) at screening.
: Not applicable.
: TJC: speaker and researcher for BioCryst, CSL-Behring, and Takeda. Researcher for KalVista and Pharvaris. Speaker for Grifols. Consultant for BioMarin and Spark. Director ACARE International Hereditary Angioedema Center. Medical Advisory Board for the HAE-A. Board of Directors for the AAAAI. RHZ-U: received consulting fees from BioCryst and Takeda, and lecture fees from Dyax, Pharming, and Takeda. HHL: received grants, personal fees, and non-financial support from CSL Behring, Pharming, and Takeda. MY, SJ: full-time employees of and own stocks/options in Takeda. HR: full-time employee of Cytel, which was contracted by Takeda to conduct statistical analyses. JA: speaker bureau member for CSL Behring, Pharming, and Takeda; and has received consultancy fees from and is a clinical trial investigator for BioCryst, CSL Behring, Pharming, and Takeda.